Science Explorer Back to mapMap
Discussion
Researcher · Ospedale D. Cotugno · Italy

Carolina Rescigno

Carolina Rescigno publishes mostly in Infectious Diseases, Oncology and Epidemiology, on topics such as COVID-19 Clinical Research Studies, COVID-19 and healthcare impacts and Long-Term Effects of COVID-19.

OpenAlex
World rank
#3,274,649
of 7,710,434 ranked researchers
Rank in Italy
#110,864
of 242,206
Works
27
Citations
504
Citations per work
18.7
h-index
10
i10-index 11Top 64% in Infectious Diseases
Carolina Rescigno

What does Carolina Rescigno research?

Carolina Rescigno's work is mostly in Medicine (61%), Immunology and Microbiology (4%).

Health Sciences: 17 works · 61.3% of their workMedicine: 17 works · 61.3% of their workInfectious Diseases: 8 works · 30.7% of their workEpidemiology: 3 works · 9.3% of their workOncology: 3 works · 9.3% of their workNeurology: 2 works · 6.7% of their workPublic Health, Environmental and Occupational Health: 1 works · 5.3% of their workEverything else: 9 works · 34.7% of their workLife Sciences: 1 works · 4.0% of their workImmunology and Microbiology: 1 works · 4.0% of their workMicrobiology: 1 works · 4.0% of their workTHEIR WORKCarolina Rescigno27works
Life Sciences4%Health Sciences61%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1761.3%
  2. Everything else934.7%
    1. Immunology and Microbiology14.0%
  1. 1Infectious Diseases31% of their works
  2. 2Oncology9% of their works
  3. 3Epidemiology9% of their works
  4. 4Neurology7% of their works
  5. 5Public Health, Environmental and Occupational Health5% of their works
  6. 6Microbiology4% of their works

Research topics

Which keywords describe Carolina Rescigno's research?

The keywords of their largest research topics: Pandemic, Epidemiology, SARS-CoV-2, ACE2 Receptor, Clinical Characteristics, Thrombosis, COVID-19 and Surgery.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 24 words, with their numbers
  1. Pandemic233 topics
  2. Epidemiology194 topics
  3. SARS-CoV-2183 topics
  4. ACE2 Receptor162 topics
  5. Clinical Characteristics121 topic
  6. Thrombosis121 topic
  7. COVID-1992 topics
  8. Surgery92 topics
  9. Cancer71 topic
  10. Immunity72 topics
  11. Mortality71 topic
  12. Vaccine72 topics
  13. Neurologic Manifestations51 topic
  14. Post-acute COVID-19 Syndrome51 topic
  15. Coronavirus41 topic
  16. spike protein41 topic
  17. Bacterial Meningitis31 topic
  18. Neisseria meningitidis31 topic
  19. Community-Acquired Pneumonia21 topic
  20. Diagnosis21 topic
  21. Diagnostics21 topic
  22. Infective Endocarditis21 topic
  23. Pneumococcal Conjugate Vaccine21 topic
  24. wastewater surveillance21 topic

Where does Carolina Rescigno work?

Carolina Rescigno's main affiliation in the publication record is Ospedale D. Cotugno, Italy.

How many publications and citations does Carolina Rescigno have?

OpenAlex counts 27 works and 504 citations for Carolina Rescigno, an h-index of 10, ranking #3,274,649 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Carolina Rescigno. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.